Tristel

Cambridge, United Kingdom Founded: 1998 • Age: 28 yrs
Infection control products are manufactured for healthcare surfaces and systems.
Annual revenue $63.6M Latest available
Total funding - 1 rounds
Employees 260 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Tristel

Tristel is a company based in Cambridge (United Kingdom) founded in 1998. The company has 260 employees as of June 30, 2024. Tristel has completed 1 acquisition, including Ecomed.

  • Headquarter Cambridge, United Kingdom
  • Employees 260 as on 30 Jun, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Tristel Plc
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $63.65 M (USD)
    10.8
    as on Jun 30, 2025
  • Net Profit
    $9.1 M (USD)
    2.33
    as on Jun 30, 2025
  • EBITDA
    $17.51 M (USD)
    27.75
    as on Jun 30, 2025
  • Latest Funding Round
    $9.21 M (USD), Post-IPO

    Jul 01, 2018

  • Investors
    Not available
  • Employee Count
    260

    as on Jun 30, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Tristel

Tristel is a publicly listed company on the LSE with ticker symbol TSTL in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: LSE · Ticker: TSTL · Sector: Health technology · UK

People of Tristel

Headcount 50-200
Employee Profiles 54
Board Members and Advisors 6
Employee Profiles
People
Jess Botting
International Distributor Relations - Europe & Africa
People
Adrian E.
Process Validation Lead
People
Jamie Dixon
Head Of Process Validation And Continuous Improvement
People
Paul Swinney
Chief Executive

Unlock access to complete

Board Members and Advisors
people
Isabel Napper
Independent Non-Executive Director

Unlock access to complete

Funding Insights of Tristel

Investments & Acquisitions by Tristel

Tristel has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Ecomed.

Investments
Premium access

Investment portfolio details for Tristel

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
-
Locked Locked 0 Locked
Premium access

Complete acquisition details for Tristel

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Tristel

Premium access

Detailed financials for Tristel

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Tristel Comparisons

Tristel Primary company
Description
Infection control products are manufactured for healthcare s...
Location
Cambridge, United Kingdom
Founded Year
1998
Annual Revenue
$63.65 M (USD)
Net Profit
$9.1 M (USD)
EBITDA
$17.51 M (USD)
Employees
260
As of 2024
Premium access

Peer comparison for Tristel

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Tristel

Premium access

Detailed competitors of Tristel

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Tristel

Premium access

Complete news archive for Tristel

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tristel

Tristel was founded in 1998 and raised its 1st funding round 20 years after it was founded.

Tristel is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Paul Swinney is the current CEO of Tristel.

As of Jun 30, 2024, the latest employee count at Tristel is 260.

Annual revenue of Tristel is $63.65M as on Jun 30, 2025.

Tristel produces infection control products for hospitals. Tristel also provides products for legionella control in water systems and contamination control in the healthcare, veterinary, food growing, food processing and pharmaceutical industries. Their products are based on their proprietary chlorine dioxide chemistry technology and are marketed as the leading replacements for aldehyde-based disinfectants. In England, Scotland and Wales, Tristel Solutions markets its products directly to National Health Service and private sector hospitals, doctor owned practices, as well as dental and veterinary establishments. Apart from UK, Tristel sells its products in other European countries as well.

Yes, Tristel is publicly traded on LSE under the ticker symbol TSTL.

Tristel has made 1 acquisition, including Ecomed.

The ticker symbol of Tristel is TSTL on LSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available